Cognitive enhancers in theory and practice: Studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease

Behavioural Brain Research

Volumn 83, Issue 1-2, 1997, Pages 15-23

  Robbins, T W ^a   McAlonan, G ^a   Muir, J L ^a   Everitt, B J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

acetylcholine; Alzheimer's disease; anticholinesterase; attention; dementia; dopamine; hippocampus; memory; noradrenaline; nucleus basalis magnocellularis

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINE; NOOTROPIC AGENT; PHYSOSTIGMINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; LEARNING; MEMORY; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031081092     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)86040-8     Document Type: Conference Paper

References (34)

1. 3 receptors mediate inhibition of acetylcholine release in cortical tissue, Nature, 338 (1989) 762-763.
2. [2] Coull J.T., Sahakian B.J. and Hodges, J.R., The alpha-2 antagonist, idazoxan, remediates certain attenional and executive dysfunction in patients with dementia of frontal type, Psychopharmacology, 123 (1996) 239-249.
3. [3] Dunnett, S.B., Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats, Psychopharmacology, 87 (1985) 357-363.
4. [4] Dunnett, S.B., Everitt, B.J. and Robbins, T.W., The basal forebrain-cortical cholinergic system. Interpreting the functional consequences of excitotoxic lesions, Trends Neurosci., 14 (1991) 494-501.
5. [5] Etherington, R.E., Mittleman, G. and Robbins T.W., Comparative effects of nucleus basalis and fimbria-fornix lesions on delayed matching and alternation tests of memory, Neurosci. Res. Commun., 1 (1987) 135-143.
6. [6] Everitt, B.J., Robbins, T.W., Evenden, J.L., Marston, H.M., Jones, G.H. and Sirkia, T.E., The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional viual discrimination: implications for cholinergic hypotheses of learning and memory, Neurosciece, 22 (1987) 441-469.
7. [7] Fibiger, H.C., Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends Neurosci, 14 (1991) 973-981.
8. [8] Gaffan, D. and Murray, E.A., Monkeys (macaco fascicularis) with rhinal cortex ablations succeed in object discrimination learning despite 24 hour intertrial intervals and fail at matching to sample despite double sample presentation, Behav. Neurosci., 106 (1992) 30-38.
9. [9] Hyman, B.T., Arriagada, P.V., Van Hoesen, G. and Damasio, A., Memory impairment in Alzheimer"s disease: an anatomical perspective. In R.W. Park,, R.F. Zec and R.P. Wilson (Eds.) Neuropsychology of Alzheimer's Disease and Other Dementias. Oxford University Press, New York, 1993, pp. 138-150.
10. [10] Lange, K.W., Robbins, T.W., Marsden, C.D., James, M., Owen, A.M. and Paul, G.M., L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology, 107 (1992) 394-404.
11. [11] Mandel, R.J. and Thal, L.J., Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats, Psychopharmacology, 96 (1998) 421-425.
12. [12] McAlonan, G.M., Wilkinson, L.S., Robbins, T.W. and Everitt, B.J., The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicit and contextual cues and spatial learning in the water maze, Eur. J. Neurosci., 7 (1995) 281-292.
13. [13] McAlonan, G.M., Dawson, G.R., Wilkinson, L.O., Robbins, T.W. and Everitt, B.J., The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed matching to sample and spatial learning in the water-maze, Eur. J. Neurosci., 7 (1995) 1034-1049.
14. [14] Muir, J.L., Dunnett, S.B., Robbins, T.W. and Everitt, B.J., Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task, Exp. Brain. Res., 89 (1992) 611-622.
15. [15] Muir, J.L., Everitt, B.J. and Robbins, T.W., AMPA-induced lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function, J. Neurosci., 14 (1994) 2313-2326.
16. [16] Muir, J.L., Everitt, B.J. and Robbins, T.W., The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral and parietal cortex lesions on a 5-choice serial reaction time task, Cerebral Cortex, 6 (1996) 470-481.
17. 3 receptor antagonist, ondansetron, Psychopharmacology, 118 (1995) 82-92.
18. [18] Muir, J.L., Page, K.J. Siranthsinghji, D.J.S., Robbins, T.W. and Everitt, B.J., Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention, Behav. Brain Res., 57 (1993) 123-131.
19. [19] Muir, J.L., Robbins, T.W. and Everitt B.J., Disruptive effects of muscimol infused into the basal forebrain on conditional discrimination and visual attention: differential interactions with cholinergic mechanisms, Psychopharmacology, 107 (1992) 541-550.
20. [20] Olton, D.S. and Wenk, G.L., Dementia: animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, New York, 1987, pp. 941-953.
21. [21] Owen A.M., James, M., Leigh, P.N., Summers, B.A., Marsden, C.D., Quinn, N.P., Lange, K.W. and Robbins, T.W., Frontostriatal cognitive deficits at different stages of Parkinson's disease, Brain, 115 (1992) 1727-1751.
22. [22] Page K.J., Everitt, B.J., Robbins, T.W., Marston, H.M. and Wilkinson, L.S., Dissociable effects on spatial water maze and passive avoidance acqusition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss, Neuroscience, 43 (1991) 457-472.
23. [23] Page, K.J. and Everitt, B.J., The distribution of neurons coexpressing immunoreactivity to AMPA sensitive glutamate receptor subtypes (GluR 1-4) and nerve growth factor receptor in the rat basal forebrain, Eur. J. Neurosci., 7 (1995) 1022-1033.
24. [24] Page, K.J., Sirinathsinghji, D.J.S. and Everitt, B.J., AMPA-induced lesions of the basal forebrain differentially affect cholinergic and non-cholinergic neurons: lesion assessment using quantitative in situ hybridization histochemistry, Eur. J. Neurosci., 7 (1995) 1012-1021.
25. [25] Perry E.K., The cholinergic hypothesis-ten years on, Br. Med. Bull., 42 (1986) 63-69.
26. [26] Robbins, T.W. and Everitt, B.J., Arousal systems and attention. In M. Gazzaniga (Ed.), The Cognitive Neurosciences, MIT Press, Cambridge, MA, 1995, pp. 903-925.
27. [27] Robbins, T.W., Everitt, B.J., Marston, H.M., Wilkinson, J., Jones, G.H. and Page, K.J., Comparative effects of ibotenic acid-and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes, Behav. Brain Res., 35 (1989) 221-240.
28. [28] Sahakian, B.J., Jones G., Levy, R., Gray, J. and Warburton, D., The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type, Br. J. Psychiatry, 154 (1989) 797-800.
29. [29] Sahakian, B.J. Owen, A.M., Morant N.J., Eagger, S.A., Boddington, S., Crayton, L., Crockford, H.A., Crooks, M., Hill, K. and Levy, R., Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using the CANTAB battery, Psychopharmacology, 110 (1993) 395-401.
30. [30] Sahakian, B.J., Coull, J. and Hodges, J.R., Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal type, J. Neurol., Neurosurg. Psychiatry, 57 (1994) 120-121.
31. [31] Sarter, M., Bruno, J.P. and Dudchenko, P., Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification, Psychopharmacology, 101 (1990) 1-17.
32. [32] Taylor, A.E., Saint-Cyr, J.A. and Lang A.E., Frontal lobe dysfunction in Parkinson's disease, Brain, 109 (1986) 845-883.
33. [33] Voytko, M.L., Olton, D.S., Richardson, R.T., Gorman, L.K. and Robin, J.R., Basal forebrain lesions in monkeys disrupt attention but not learning and memory, J. Neurosci., 14 (1994) 167-186.
34. [34] Wonnacott, S. Irons, J. Rapier, C., Thorne, B. and Lunt, G.G., Presynaptic modulation of transmitter release by nicotine receptors. In A. Nordberg, A.K. Fuxe, B. Holmstedt and A. Sundwall (Eds.), Progress in Brain Research, Elsevier, Amsterdam, 1989, pp. 157-163.